<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Chitosan microcapsules and chitosan membrane for drug delivery systems</title>
  </titleInfo>
  <name type="personal">
    <namePart>Anal, Anil Kumar</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Stevens, Willem Frans</namePart>
    <role>
      <roleTerm type="text">Chairperson</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Korbtham Sathirakul</namePart>
    <role>
      <roleTerm type="text">Examination committee</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Suwalee Chandrkrachang</namePart>
    <role>
      <roleTerm type="text">Examination committee</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Rakshit, Sudip Kumar</namePart>
    <role>
      <roleTerm type="text">Examination Committee</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Montet, Didier</namePart>
    <role>
      <roleTerm type="text">Examination committee</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Pakorn Nuchnoi</namePart>
    <role>
      <roleTerm type="text">Examiantion Committee</roleTerm>
    </role>
  </name>
  <name type="corporate">
    <namePart>Government of Austria</namePart>
    <role>
      <roleTerm type="text">Scholarship donor</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">series</genre>
  <genre authority="marc">technical report</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">th</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Bangkok</placeTerm>
    </place>
    <publisher>Asian Institute of Technology</publisher>
    <dateIssued>1998</dateIssued>
    <issuance>continuing</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <extent>78 leaves</extent>
  </physicalDescription>
  <abstract>In this study, both chitosan beads and chitosan membrane have been investigated for  applications in systems of controlled release of phaimaceuticals. Chitosan beads can be prepai-ed  by microencapsulation of chitosan droplets. Microencapsulation comprises various technologies  that can be used to coat small particles of solid or droplets of liquid dispersion with a thin  coating layer. The dropping of dissolved chitosan into a solution of tripolyphosphate (TPP) leads  instantaneously to the formation of beads by ionotropic gelation without using any sophisticated  instruments. Conditions of microencapsulation have been investigated to optimize bead  formation and entrapment of the model protein, bovine serum albumin (BSA). The speed of  droppings, a slight stirring speed of TPP solution, 5-7 cm dropping distance from the surface of  TPP solution and the type, concentration, and viscosity of chitosan solution were fotmd the  major influensive parameters to form smooth and spherical chitosan beads. Crosslinking  between chitosan and TPP occurs within 15 minutes. The pH 7.2 ofTPP was found the optimum  pH for the maximum entrapment of bovine serum albumin (BSA), which was used as model  drug for this study. The degree of deacetylation of chitosan showed an influensive on the  entrapment of BSA while the concentration ofTPP, viscosity of chitosan solution ai1d more than  3% load of BSA did not have any effect. The chitosan beads/microcapsules were found to swell  in acidic medium (0.1 N HCl). The release of BSA from the chitosan microcapsules was found  depending upon the pH of the dissolution medium, drying condition, and the type of chitosan.  Chitosan membrane prepared from chitosan with a 95% degree of deacetylation showed  similar behavior as of commercially available cellulose membrane. The equilibrium dialysis for  all model drugs aspirin, phenobarbitone Na salt, and Sulfanilamide occurred within two hours in  both cellulose and chitosan membranes. The fraction of unbound drugs could be determined by  using chitosan membrane. The unbound fractions of drugs obtained by using commercial  regenerated cellulose membrane were comparable with those obtained by using chitosan  membrane.</abstract>
  <note>A thesis submitted in partial fulfillment of the requirements  for the degree of Master of Science, School of Environment, Resources and Development</note>
  <note>Thesis (M.Sc.) - Asian Institute of Technology, 1998</note>
  <subject authority="lcsh">
    <topic>Chitosan</topic>
  </subject>
  <relatedItem type="series">
    <titleInfo>
      <title>Thesis ; no. BP-98-12</title>
    </titleInfo>
    <name type="corporate">
      <namePart>Asian Institute of Technology.</namePart>
      <namePart/>
    </name>
  </relatedItem>
  <identifier type="uri">http://203.159.5.9/ait-thesis/detail.php?q=B13238</identifier>
  <location>
    <url displayLabel="Full-Text">http://203.159.5.9/ait-thesis/detail.php?q=B13238</url>
  </location>
  <recordInfo>
    <recordCreationDate encoding="marc">200499</recordCreationDate>
    <recordChangeDate encoding="iso8601">20260817172702.0</recordChangeDate>
  </recordInfo>
</mods>
